Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go?

Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers

(2011) I.-S. Park et al.   Cancer Prevention Research

Nuclear translocation of β-catenin and decreased expression of epithelial cadherin in human papillomavirus-positive tonsillar cancer: an early event in human papillomavirus-related tumour progression?

(2011) Markus Stenner et al.   HISTOPATHOLOGY

Expression of p53, p16INK4A, pRb, p21WAF1/CIP1, p27KIP1, cyclin D1, Ki-67 and HPV DNA in sinonasal endophytic Schneiderian (inverted) papilloma

(2010) Giuseppe Altavilla et al.   ACTA OTO-LARYNGOLOGICA

Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study

(2010) M. Merlano et al.   ANNALS OF ONCOLOGY

Interaction of viral oncoproteins with cellular target molecules: infection with high-risk vs low-risk human papillomaviruses

(2010) DAVID PIM et al.   APMIS

The role of human papillomavirus in head and neck cancer

(2010) CHRISTEL BRAEMER LAJER et al.   APMIS

Tobacco Use in Human Papillomavirus-Positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor Recurrence

(2010) J. H. Maxwell et al.   CLINICAL CANCER RESEARCH

Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review

(2010) Carolin M. Grimminger et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer

(2010) A Wu et al.   GENE THERAPY

Current understanding of the mechanism of HPV infection

(2010) John T. Schiller et al.   GYNECOLOGIC ONCOLOGY

Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus

(2010) Abigail I. Wald et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

p16INK4A overexpression is frequently detected in tumour-free tonsil tissue without association with HPV

(2010) Boris Klingenberg et al.   HISTOPATHOLOGY

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection

(2010) Sven-Eric Olsson et al.   Human vaccines & immunotherapeutics

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Distribution of human papillomavirus types in the anogenital tract of females and males

(2010) Luisa Barzon et al.   JOURNAL OF MEDICAL VIROLOGY

The Inhibitory Action of P56 on Select Functions of E1 Mediates Interferon's Effect on Human Papillomavirus DNA Replication

(2010) P. Saikia et al.   JOURNAL OF VIROLOGY

HPV-associated head and neck cancer: a virus-related cancer epidemic

(2010) Shanthi Marur et al.   LANCET ONCOLOGY

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

(2010) K. Kian Ang et al.   NEW ENGLAND JOURNAL OF MEDICINE

The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome

(2010) Pernille Lassen   RADIOTHERAPY AND ONCOLOGY

Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection

(2010) Subhashini Jagu et al.   VACCINE

Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments

(2010) Hans-Ulrich Bernard et al.   VIROLOGY

Mechanisms of cell entry by human papillomaviruses: an overview

(2010) Caroline AJ Horvath et al.   Virology Journal

Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease

(2009) Adam J Donne et al.   ANTIVIRAL THERAPY

Interferon for the treatment of genital warts: a systematic review

(2009) Jin Yang et al.   BMC INFECTIOUS DISEASES

Diversity of human papillomavirus types in periungual squamous cell carcinoma

(2009) A. Kreuter et al.   BRITISH JOURNAL OF DERMATOLOGY

Human papillomavirus in oral leukoplakia is no prognostic indicator of malignant transformation

(2009) Shih-Wei Yang et al.   Cancer Epidemiology

Epigenetic Silencing of Interferon-  in Human Papillomavirus Type 16-Positive Cells

(2009) B. Rincon-Orozco et al.   CANCER RESEARCH

Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1

(2009) M. J. Lace et al.   CARCINOGENESIS

The regulation of cell proliferation by the papillomavirus early proteins

(2009) N. Abdul Hamid et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

RNA interference silences the human papillomavirus 6b/11 early gene E7 in vitro and in vivo

(2009) X. Z. Chen et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

HPV16 Tumor Associated Macrophages Suppress Antitumor T Cell Responses

(2009) A. P. Lepique et al.   CLINICAL CANCER RESEARCH

Genetic Signatures of HPV-related and Unrelated Oropharyngeal Carcinoma and Their Prognostic Implications

(2009) J. P. Klussmann et al.   CLINICAL CANCER RESEARCH

Human papillomavirus-related head and neck tumors: clinical and research implication

(2009) Amanda Psyrri et al.   CURRENT OPINION IN ONCOLOGY

Current trends in initial management of oropharyngeal cancer: the declining use of open surgery

(2009) Missak Haigentz et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

Topical treatment of CIN 2+ by cidofovir: Results of a phase II, double-blind, prospective, placebo-controlled study

(2009) C. Van Pachterbeke et al.   GYNECOLOGIC ONCOLOGY

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma?

(2009) Anders Näsman et al.   INTERNATIONAL JOURNAL OF CANCER

Oropharyngeal Squamous Cell Carcinoma Treated With Radiotherapy or Radiochemotherapy: Prognostic Role of TP53 and HPV Status

(2009) Carlo Fallai et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

The Relationship Between Human Papillomavirus Status and Other Molecular Prognostic Markers in Head and Neck Squamous Cell Carcinomas

(2009) Christina S. Kong et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

More than a decade on: review of the use of imiquimod in lower anogenital intraepithelial neoplasia

(2009) M Mahto et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis

(2009) Niladri Ganguly et al.   JOURNAL OF BIOSCIENCES

Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck

(2009) Pernille Lassen et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparative Prognostic Value of HPV16 E6 mRNA Compared With In Situ Hybridization for Human Oropharyngeal Squamous Carcinoma

(2009) Wei Shi et al.   JOURNAL OF CLINICAL ONCOLOGY

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

(2009) Darron R. Brown et al.   JOURNAL OF INFECTIOUS DISEASES

Oral Sexual Behaviors Associated with Prevalent Oral Human Papillomavirus Infection

(2009) Gypsyamber D’Souza et al.   JOURNAL OF INFECTIOUS DISEASES

Human Papillomaviruses and the Interferon Response

(2009) Melanie Beglin et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

E6 and E7 Gene Silencing and Transformed Phenotype of Human Papillomavirus 16-Positive Oropharyngeal Cancer Cells

(2009) T. Rampias et al.   JNCI-Journal of the National Cancer Institute

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

(2009) Nubia Muñoz et al.   LANCET

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET

Development of therapeutic HPV vaccines

(2009) Cornelia L Trimble et al.   LANCET ONCOLOGY

Transoral resection of tonsillar squamous cell carcinoma

(2009) Eric J. Moore et al.   LARYNGOSCOPE

Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas

(2009) Jos M. J. A. A. Straetmans et al.   LARYNGOSCOPE

P21Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis

(2009) Harriët C Hafkamp et al.   MODERN PATHOLOGY

Feasibility of transoral lateral oropharyngectomy using a robotic surgical system for tonsillar cancer

(2009) Young Min Park et al.   ORAL ONCOLOGY

HPV E6 protein interacts physically and functionally with the cellular telomerase complex

(2009) X. Liu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Proteomic analysis of human papillomavirus-related oral squamous cell carcinoma: Identification of thioredoxin and epidermal-fatty acid binding protein as upregulated protein markers in microdissected tumor tissue

(2009) Christian Melle et al.   PROTEOMICS

Cell-permeable artificial zinc-finger proteins as potent antiviral drugs for human papillomaviruses

(2008) Takashi Mino et al.   ARCHIVES OF VIROLOGY

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Type-Dependent Integration Frequency of Human Papillomavirus Genomes in Cervical Lesions

(2008) S. Vinokurova et al.   CANCER RESEARCH

Prevalence, Acquisition, and Clearance of Cervical Human Papillomavirus Infection among Women with Normal Cytology: Hawaii Human Papillomavirus Cohort Study

(2008) Marc T. Goodman et al.   CANCER RESEARCH

Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1

(2008) Fulvia Terenzi et al.   EMBO JOURNAL

Therapeutic human papillomavirus vaccines: current clinical trials and future directions

(2008) Chien-Fu Hung et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: Importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention

(2008) David Jenkins   GYNECOLOGIC ONCOLOGY

Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas

(2008) Harriët C. Hafkamp et al.   INTERNATIONAL JOURNAL OF CANCER

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis

(2008) Hugo De Vuyst et al.   INTERNATIONAL JOURNAL OF CANCER

Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis

(2008) A.J. Donne et al.   INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY

EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer

(2008) Bhavna Kumar et al.   JOURNAL OF CLINICAL ONCOLOGY

Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial

(2008) C. Fakhry et al.   JNCI-Journal of the National Cancer Institute

Dysregulated molecular networks in head and neck carcinogenesis

(2008) Alfredo A. Molinolo et al.   ORAL ONCOLOGY

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine

(2008) Elmar A. Joura et al.   VACCINE

Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cells

(2008) Chi-Mu Chuang et al.   VACCINE